Powell Fred M 4
4 · LAVA Therapeutics NV · Filed Nov 17, 2025
Insider Transaction Report
Form 4
Powell Fred M
Chief Financial Officer
Transactions
- Disposition to Issuer
Common Shares
2025-11-13−65,000→ 0 total - Disposition to Issuer
Share Options (Right to Buy)
2025-11-13−124,700→ 0 totalExercise: $0.93Exp: 2035-02-12→ Common Shares (124,700 underlying)
Footnotes (2)
- [F1]Disposed of pursuant to that certain Purchase Agreement, dated August 3, 2025, by and between the Issuer and XOMA Royalty Corporation (as amended, the " Purchase Agreement") in exchange for (i) $1.04 in cash per share (the "Cash Amount"), plus (ii) one non-transferable contingent value right ("CVR") per share.
- [F2]This option was cancelled pursuant to that certain Purchase Agreement in exchange for cash and CVRs (without interest and net of applicable withholding tax and other applicable deductions) in an amount equal to (i) the excess of $1.04 over the per share exercise price of such option multiplied by the total number of shares underlying such in option and (ii) one CVR per share underlying such in-the-money option.